Clinical Trial Update: Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether bevacizumab affects intratumoral pharmacokinetics of 5-fluorouracil in metastatic colorectal cancer using PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Avastin (bevacizumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Colorectal Cancer, Neoplasm Metastasis | Phase 2 | Status: COMPLETED